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I have chosen some thoughts about recent 
clinical advances in the diagnosis of cerebral vascu-
lar disease, which I feel are appropriate for this 
paper, confining my discussion to the signs, symp-
toms, natural history, and risk factors of cerebral 
vascular disease. 
Atherosclerosis and stenosis of the cerebral 
vessels result in occlusion and embolization of the 
brain parenchymatous vessels, particularly if the · 
atherosclerotic lesions of the vessels not only stenose 
but cause ulcerated lesions as well, which will give 
rise to fibrinoplatelet emboli and even large, red 
emboli. This process results in slow blood flow, 
turbulence, erythrocyte and platelet aggregation-
with local anoxia resulting in endothelial damage, 
the loss of plasma fluid-resulting in brain edema, 
and compression of capillaries and venules. This 
vicious cycle is depicted in Figure 1, showing a 
worsening of the ischemic and hemorrhagic infarc-
tion. In the area of circulation around the ischemia, 
hyperproteinemia and hemoconcentration occur, 
which tend to cause deposition of the platelets. 
One can easily see these platelets under direct 
examination of the microcirculation of the brain, 
showing increased viscosity and the tendency toward 
thrombosis and further infarction. 
Hypertension will promote atherosclerosis, and 
certain other systemic factors such as hypotension 
or lowered blood pressure, particularly much below 
80-90 mm Hg (systolic), will worsen the situation 
because of distorted autoregulation. Associated poly-
,:, This is an edited transcription of a lecture presented 
by Dr. Meyer at the 27th Annual Stoneburner Lecture 
Series, February 7, 1974, at the Medical College of Vir-
ginia, Richmond. 
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cythemia or sickle cell disease will be aggravated 
by the situation. 
Conversely, anticoagulants and platelet in-
hibitors tend to prevent the aggregation of these 
platelets and erythrocytes as welt as preventing the 
development of thrombosis. Systemic dehydration 
will have an adverse effect while collateral blood 
flow enhancement will tend to improve the situa-
tion. Hyperlipidemia and hyperlipemia will cause 
aggravation for several reasons-they promote 
atherosclerosis and they enhance the tendency to-
ward platelet aggregation and changes in the proper-
ties of the blood. Hypothermia will tend to protect 
the patient by decreasing brain metabolism; sys-
temic anoxia will make him worse. Neurotrans-
mitters are released, probably as a result of the 
deleterious changes. 
Let me summarize the risk factors with which 
the American Heart Association Committee con-
cerned itself in 1971 ( 1), which we now agree are 
reasonably well established (Table 1). A hyper-
tension of 160/ 95 mm Hg is present in at least 
85 % of cases-a significant risk factor, the control 
of which is one of the great advances in prevention 
of stroke. EKG abnormalities occur in 60- 70% of 
our patients with stroke, consisting of left ventri-
cular hypertrophy (LVH) , myocardial infarction 
(Ml), or a recent or old dysrhythmia. Clinical 
angina, myocardial infarction, claudication, dimin-
ished pulses, bruits-all are associated with a stroke 
patient and should be sought. Diabetes mellitus 
occurs, depending upon how you evaluate it, in at 
least 30-40% of these patients. Certainly, an ele-
vated fasting blood sugar and an abnormal glucose 
tolerance test or a two-hour postprandial blood 
sugar exceeding 160 mg% should be considered sig-
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nificant. Recently, we have been studying the blood 
lipid profile, another important factor, with Dr. 
Gotto at our institution. Type IV lipidemia, par-
ticularly, is a risk factor that occurs in approxi-
mately 30% of these patients. Other factors-
smoking, polycythemia, erythrocytosis, gout, and 
hyperuricemia should be evaluated. Of our patients 
with cerebral vascular symptoms and extracranial 
occlusive disease, 43% had hyperlipoproteinemia, 
and almost all of these were type IV. Of our pa-
tients with intracranial small and large vessel lesions, 
20% had hyperlipoproteinemia, but of those with 
intracranial small vessel disease, only 3% had hyper-
lipoproteinemia. As might be expected, of those with 
combined extra- and intracranial lesions, there is 
an incidence of 25%. Those with a normal 
angiogram have, essentially, a normal lipoprotein 
pattern. In summary, one can say that hyperlipo-
proteinemia type IV is a significant aspect of extra-
cranial occlusive disease. 
It is wise in evaluating your patients, particu-
larly the young patients with hypotension and 
extracranial occlusive cerebral vascular disease, to 
look for fibromuscular dysplasia. Acute myocardial 
infarction is seen in 10% of patients with acute 
stroke and in 60% of those with chronic arterio-
sclerotic heart disease. As illustrated in Table 2, a 
stroke-prone individual is one who has not yet had 
a stroke but is likely to because of the risk factors 
present in his profile. Thus, a patient with hypo-
tension, diabetes, hyperlipidemia, and/ or arterio-
sclerotic heart disease, who is obese or a heavy 
smoker, is extremely apt, on a prospective clinical 
trial period, to have a stroke and is at great risk. 
Similarly, patients having transient ischemic 
attacks (TIA's) or reversible ischemic neurological 
deficits (RIND's) will proceed to a stroke 30-50% 
of the time within a five-year period. Transient 
ischemic attack is a neurological deficit existing, 
due to cerebral vascular disease, for 24 hours or 
less; whereas reversible ischemic neurological deficit 
is a little stroke lasting longer than 24 hours but 
with recovery in about three weeks. A patient who 
has had a neurological deficit for longer than 24 
hours, progressing in the acute stage is said to have 
a stroke in evolution. A stabilized neurological 
deficit appears in a patient who has a stroke in 
the past and comes in sometime later in a stable 
condition. Table 3 represents a summary of several 
natural history studies of cerebral vascular disease, 
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one-third progress within five years to irreversible 
cerebral infarction; one-third continue to have TIA's 
and therefore continue to be at risk of cerebral in-
farction; and one-third seem to cease having TIA's 
spontaneously within five years, without further neu-
rological disorder, but they are at great risk of 
suffering other complications of atherosclerosis such 
as myocardial infarction. 
The mechanism of TIA's is still under con-
sideration by many scientists and physicians. Cer-
TABLE 1 
RiSK FACTORS IN STROKE* 
1. Hypertension of 160/ 95 mm Hg (present in 85% of 
cases) 
2. Cardiac Enlargement by X-ray 
3. EKG Abnormalities, LVH, MI, and Dysrhythmia 
4. Clinical Angina, MI, Claudication, Diminished Pulses, 
and Bruits 
5. Diabetes Mellitus (2 hr pp 160 mg% or more; FBS 120 
mg% or more) 





* Reprinted by permission of the American Heart As-
sociation, Inc. (1) 
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TABLE 2 
CLINICAL CLASSIFICATIONS 
I. "Stroke-prone" individual 
2. TIA's and RIND's 
3. Stroke in evolution and patients with moderate-to-
severe neurological deficits still in acute stage 
4. Stabilized neurological deficits 
tainly, the two major headings are recurrent 
fibrinoplatelet emboli and hemodynamic factors. 
What are the remediable mechanisms in TIA's 
(Table 4)? First of all , there is embolization for 
which doctors have advanced treatment. Cardiac 
dysrhythmias can cause cerebral vascular symptoms 
simply by decreasing cardiac output when the rate 
of the heart exceeds 160 or falls below 60. Transient 
hypotension can cause cerebral vascular symptoms 
as well, particularly if the patient has dysautoregu-
lation or impaired autoregulation of the brain. Hy-
pertension with spasm of cerebral vessels, first de-
scribed many years ago and then abandoned, is now 
well established as a significant factor. Hypogly-
cemia, a relatively rare factor, can cause localized 
neurological deficits but will respond to the admin-
istration of glucose. Likewise, polycythemia, the 
subclavian innominate steal syndrome, severe ane-
mia, kinking of vessels in the neck, and external 
compression may, by such things as osteophytes 
and cervical spondylosis, give rise to TIA's. 
While it was considered dangerous at one point 
to lower elevated blood pressure in patients with 
stroke or cerebral vascular symptoms, it now seems 
clear that controlling the hypertension improves the 
prognosis. In a series of hypertensive stroke patients 
treated with Aldomet® for one-to-two weeks, we 
noted that cerebral blood flow actually increased as 
the mean arterial blood pressure was decreased sig-
nificantly and thereby decreased cerebral vascular 
resistance. 
Figure 2 is a sketch of a very important concept 
TABLE 3 
TRANSIENT IscHEM!C ATTACKS* 
1 / 3 --> Irreversible cerebral infarctions 
l / 3 --> Continue to have TIA's 
1 / 3 --> Cease in five years 
* It is impossible to predict into which category an 
individual patient with TIA's will fall . 
TABLE 4 
REMEDIAL MECHANISMS iN TRANSIENT [SCHEMIC ATTACKS 
I. Embolization 
2. Cardiac dysrhythmia 
3. Transient hypotension 
4. Severe hypertension with spasm of cerebral vessels 
5. Hypoglycemia 
6. Polycythemia 
7. Subclavian, innominate steal 
8. Severe anemia 
9. Kinking of vessels 
I 0. External compression 
of how an ulcerated plaque in the carotid artery 
can be a source of cerebral embolism. Recurrent 
cerebral embolism with recurrent TIA's may occur 
in the same distribution repeatedly-a very im-
portant warning sign. Thus the ulcerated plaque 
may release the embolus which may then lodge 
in the middle cerebral artery territory, causing tur-
bulent flow. Circulating fibrinolysin, apparently 
present in the body normally but probably decreased 
in these patients, tends to dissolve the fibrinoplate-
let deposition. Platelet aggregate inhibitors, such as 
aspirin, Persantine®, sulfinpyrazone, along with anti-
coagulants, tend to inhibit emboli. Today, there is 
a greater tendency to use platelet inhibitors rather 
than anticoagulants. 
We studied cerebral embolization in 42 cases 
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were important as a source of fibrinoplatelet emboli 
to the brain. Rheumatic heart disease may also 
cause em boli formation; arteriosclerotic heart disease 
may cause emboli as a result of myocardial infarc-
tion, pacemaker failure, or dysrhythmias. Carotid 
plaques emerge along with cardiac disorders as the 
most common causes, accounting for almost all 
emboli. There are rare causes such as aortic aneu-
rysms with mural thrombi, carotid stenosis without 
ulcerated plaque, carotid kinking, and vertebral 
thrombosis. Two types of embolism can result from 
the justifiable insertion of prosthetic valves, although 
it must be emphasized that 90% or more of patients 
receiving them show no complications from their 
use, and they should be considered a great advance 
in surgical treatment. The fibrinoplatelet emboli that 
arise from the valve, particularly if it is a ball valve 
with a rough surface, can be seen and can be treated 
with Persantine®. The larger types of emboli respond 
to anticoagulants. 
Although we never used to think that seizures 
occurred with cerebral vascular disease, it is now 
quite apparent that they commonly occur in cere-
bral embolization. Neurological findings show that 
abnormal tendon jerks. and mot.or deficits are com-
mon and cranial nerve involvement is a frequent 
physical finding; herrlianopsia is relatively frequent 
as well. Regarding the work-up, the arteriogram is 
by far the most valuable test and will usually show 
the occluded vessel early in the course of disease. 
We were able to show the occluded vessel in 93% 
of our cases. In 90% of cerebral embolisms, the 
EEG is abnormal. The brain scan is abnormal in 
91 % of the cases and the cerebrospinal fluid ( CSF) 
pressure is increased in about 50% of the cases 
(Table 5). The left hemisphere is involved more 
often than the right in cerebral embolisms; the 
incidence was about twice as high in our study. 
Sixty-five percent of emboli of cardiac origin and 
64% of carotid plaque origin lodge in the left hemi-
sphere. This tendency can probably be explained 
by the anatomical distribution of the aorta and the 
great vessels in the neck. The innominate artery 
tends to go against the vector of force or the thrust 
of the cardiac output; it is somewhat protected and 
emboli would tend to go to the right arm rather 
than into the carotid or vertebral artery. The left 
common carotid artery, however, is particularly 
prone to receive the emboli, since it lies directly 
in the direction of the thrust of the cardiac output. 
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on the left. It could perhaps be argued also that 
a patient who is dysphasic and has a left hemisphere 
lesion is more likely to be diagnosed, but we rejected 
that argument in our own prospective study since 
we think we examined all patients very carefully. 
In our institution, patients with vertebral basilar 
insufficiency have a different type of transient 
ischemic attack from patients with carotid emboli; 
they tend to have more postural vertigo, dizziness, 
photopsia, or homonymous or altitudinal hemianop-
sia. We feel that is because the process of ischemia 
of the brain stem itself involves those centers that 
are concerned with autoregulation. There is evidence 
now from many laboratories showing that auto-
regulation, the property of the brain enabling it 
to maintain a constant blood flow despite changes 
in the perfusion pressure, is due, in part, to the 
neurogenic innervation; this property has a brain 
stem or diencephalic-brain stem origin. Ischemia in 
this area wilI damage the autoregulation process. 
A fall in cerebral perfusion pressure will cause a 
decrease in cerebral blood flow (CBF), and the 
patient will become dizzy and symptomatic. Data 
from analysis of the sites of lesions in acute and 
in chronic strokes correlated with the delta CBF 
over the delta cerebral perfusion pressure (which 
happens to be called the autoregulation index) 
indicate that the effects are more severe in the 
acute stages, especially in those patients with brain 
stem and subcortical infarction as compared to pa-
tients with cortical infarction. Increased intracranial 
pressure is relevant in cerebral infarction. 
Cerebral edema can be lethal. We have tried 
to combat this with hyperosmolar agents; glycerol 
seems to be the best agent that we have evaluated 
in cerebral vascular disease. We find that it is better 
to treat the patient with 10% glycerol intravenously 
for six days rather than four. Glycerol ( one should 
not use more than 10% ) seems to benefit metabo-
lism as well as lower intracranial pressure; it is 
another source of energy for the brain. 
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Finally, I would like to make a few remarks 
about transient global amnesia and dementia as a 
result of vertebral basilar insufficiency. Transient 
global amnesia and dementia effect persons of middle 
age; they have attacks of loss of memory for a period 
of 24 hours and then make a more or less complete 
recovery. During the attacks, they do not lose per-
sonal identity and knowledge of self, but they have 
loss of memory for just about everything of recent 
occurrence. They are able to carry out routine 
behavior; they can respond when spoken to; they 
may be rather pale and sweaty. The origin of this 
interesting syndrome being unknown, epilepsy, mi-
graine and various equivalents, and also cerebral 
vascular disease were considered as possibilities. 
We have studied a fairly large series of these patients, 
having followed them now for an interval of two-
to-three years. They actually have vertebral basilar 
insufficiency symptoms in addition to the attacks 
of transient global amnesia. They have drop at-
tacks, ataxia, vertigo and nausea, vomiting, nystag-
mus, dizziness, light-headedness, syncope, diplopia, 
oscillopsia, paresthesias alternating from side to side, 
circumoral paresthesias, tremor, cortical blind-
ness, episodic bilateral blurred vision, occipital 
headaches-all of which are symptoms of vertebral 
basil ar insufficiency. When we analyzed them in 
terms of their age, the youngest was 48 years of age 
and the oldest was 95 with a mean of about 70; 
so it is a disease of late-middle-to-'early-elderly aged 
individuals. We noted that the cerebral blood flow 
measµred in these patients was reduced; the major 
reduction was in the occipital area, in the distribu-
tion of the posterior cerebral arteries . We then 
analyzed the patients for the risk factors for cerebral 
vascular disease mentioned previously; it is ap-
parent that these patients do have a high incidence 
of hypertension, hyperlipidemia, coronary artery 
disease of one sort or another, and diabetes mellitus. 
A study of their natural histories, prospectively, 
indicates that they frequently have had recurrent 
attacks of transient global amnesia, often resulting 
in dementia ; this leads to amnesic stroke with per-
manent loss of memory and gross dementia in a 
vast number of cases. These patients usually have 
abnormal EEG's. Bjtemporal EEG's showing oc-
cipital slow waves are found most often; occasion-
ally, bifrontal slow waves are seen as well. Angio-
grams of 12 patients revealed vertebral basilar 
arterial disease in the majority of them. Occlusion 
or stenosis of the posterior cerebral artery was 
extremely common. Thus, clearly, this disease is 
due to vertebral basilar insufficiency, and it is prob-
able that the posterior cerebral artery is responsible 
for loss of memory. 
I have tried to summarize what I consider to 
be recent and, I think, relevant and important clini-
cal findings contributed by neurologists, neurosur-
geons, and internists in the past few years on th e 
subject of cerebral vascular disease. 
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